This federal contract award is for the delivery of 4,566,708,453 units of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,626.84 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/13/25, 9:56 AM